CIK: 0001119376 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $33,094 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Vereit | 1,975,000 | $18,249 | 55.1% | $8.18 | — | Common | 92339V100 |
| — | Mylan NV | 175,100 | $3,520 | 10.6% | $20.10 | — | Common | N59465109 |
| CPRI | Capri Holdings Ltd | 82,500 | $3,147 | 9.5% | $43.70 | -21.0% | Common | G1890L107 |
| AMZN | Amazon.com Inc. | 1,000 | $1,848 | 5.6% | $93.15 | -5.0% | Common | 023135106 |
| META | 8,500 | $1,745 | 5.3% | $159.79 | +20.4% | Common | 30303M102 | |
| — | Ishares Gold Trust | 112,000 | $1,624 | 4.9% | $12.66 | — | ETF | 464285105 |
| NVCR | Novocure | 10,000 | $843 | 2.5% | $17.92 | +350.3% | Common | G6674U108 |
| GLD | SPDR Gold Shares ETF | 4,500 | $643 | 1.9% | $125.23 | — | ETF | 78463V107 |
| IMRN | Immuron Limited | 107,101 | $389 | 1.2% | $8.61 | — | Warrants | 45254U101 |
| SPY | SPDR S&P 500 ETF | 1,200 | $386 | 1.2% | $130.73 | — | ETF | 78462F103 |
| XLF | SPDR Financial ETF | 8,500 | $262 | 0.8% | $27.59 | — | ETF | 81369Y605 |
| CRSP | Crispr Therapeutics | 3,800 | $231 | 0.7% | $54.60 | 0.0% | Common | H17182108 |
| — | Homology Medicines | 10,000 | $207 | 0.6% | $22.90 | — | Common | 438083107 |